PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |infection |
| Sentences | 1297 |
| PubMedID- 21450832 | Following infection with the hepatitis c virus (hcv), in most cases immunity fails to eradicate the virus, resulting in slowly progressing immunopathology in the hcv-infected liver. |
| PubMedID- 23677838 | Osteoporosis is increasingly reported in the aging hiv-positive population, and co-infection with hepatitis c virus (hcv) may further increase the risk of osteoporosis. |
| PubMedID- 24274835 | Study design and methods: plasma samples from 11 donors donating between july 2005 and june 2010, whose test results revealed recent infection with hepatitis b, were available for further analysis. |
| PubMedID- 25579804 | Continuous hepatic inflammation as a result of chronic infection with the hepatitis c virus may lead to the development of fibrosis and eventually cirrhosis. |
| PubMedID- 21319289 | Second neoplasms appeared in 3 patients, 1 of whom died of hepatocellular carcinoma following infection with hepatitis b. |
| PubMedID- 25427909 | Overwhelming evidence suggests a strong role of infection with hepatitis b and c virus (hbv and hcv), alcohol abuse, as well as metabolic diseases such as obesity and diabetes either individually or synergistically to cause or exacerbate the development of liver cancers. |
| PubMedID- 26035647 | Chronic infection with hepatitis c virus (hcv) is characterized by liver fibrosis and cirrhosis, metabolic disorders (steatosis, insulin resistance, iron overload) and liver cancer . |
| PubMedID- 22857383 | Liver infection with hepatitis b virus (hbv), a dna virus of the hepadnaviridae family, leads to severe disease, such as fibrosis, cirrhosis and hepatocellular carcinoma. |
| PubMedID- 23401707 | infection with hepatitis b virus (hbv) is a critical health problem worldwide. |
| PubMedID- 25728498 | Background & aims: early age at infection with hepatitis b virus (hbv) increases the risk of chronic infection. |
| PubMedID- 25396023 | It may suffice to add that, co-infection with hepatitis b increases the risk of hepatotoxicity from antiretroviral therapy at least 3-5 fold and can pose challenges to treatment modalities . |
| PubMedID- 22205621 | infection with hepatitis c virus (hcv) affects approximately 170 million people worldwide. |
| PubMedID- 24088395 | Some studies show that dual infection with hiv and hepatitis c may affect cognition , yet the largest women only study (n =1338) recently found no such effect showing the importance of on-going evidence gathering and specific data on women. |
| PubMedID- 24434240 | Currently, the infection with the hepatitis e virus represents the most frequent cause for acute hepatitis and jaundice in the world. |
| PubMedID- 23580880 | For the purposes of this study, patients were interviewed about demographic and socioeconomic data (age, race, education, marital status, main occupation, personal and family income, receipt of social security benefits) and from medical records, data were collected on hemophilia and comorbidities (type and severity of hemophilia, presence of a clotting factor inhibitor, presence of infection with hepatitis b virus, hepatitis c, and human acquired immunodeficiency virus, target joints) and on the treatment of the coagulopathy (age at diagnosis, participation in the emergency home infusion program, physical activity habits, physical therapy and clotting factor consumption in the previous 12 months). |
| PubMedID- 23426905 | Chronic viral infection with the hepatitis b virus (hbv) or hepatitis c virus (hcv) appears to be the most significant causes of hcc (4). |
| PubMedID- 25615823 | In spite of a number of well-established risk factors for liver cancer, including chronic infection with hepatitis b virus (hbv) or hepatitis c (hcv), less attention, however, has been paid to the role of dietary factors except for alcohol abuse and aflatoxin contamination in the development of this malignancy . |
| PubMedID- 20607043 | The results indicate that chronic alcohol abuse was the most common risk factor (57.2%), followed by infection with hepatitis b and c viruses (hbv: 10.9% and hcv: 20.5%). |
| PubMedID- 22706272 | The median time from diagnosis of infection with hepatitis b virus was 3 years (range, 1 month to 31 years). |
| PubMedID- 22674399 | Those reporting infection with hepatitis b virus (hbv) or human immunodeficiency virus (hiv) were excluded. |
| PubMedID- 21232158 | Hiv infection is linked with hepatitis c infection (hcv), which is associated with insulin resistance and diabetes, due to increased intrahepatic tumour necrosis factor (tnf α) and hepatic steatosis. |
| PubMedID- 25654087 | Risk factors for hcc include infection with hepatitis b (hbv) and hepatitis c viruses (hcv), history of diabetes mellitus, nonalcoholic fatty liver disease and cirrhosis, heavy alcohol consumption, and cigarette smoking . |
| PubMedID- 23276803 | Hepatic fibrosis largely mediates this effect and infection with hepatitis c virus (hcv) is the most common cause. |
| PubMedID- 21573166 | Among the well known risk factors for hcc, chronic infection with hepatitis b (hbv) or c (hcv) virus is present in more than 85% of primary liver cancers 1. |
| PubMedID- 23590585 | This accelerated response by chronic iron overload could be involved in the promotion of hepatocellular carcinogenesis under infection with hepatitis viruses. |
| PubMedID- 26481253 | Purpose: with daas still only being licensed for chronic hcv infection, the ongoing epidemic of acute hepatitis c (ahc) infection among msm highlights the need to identify factors allowing for optimal hcv treatment outcome. |
| PubMedID- 21187906 | Chronic infection with the hepatitis c virus (hcv) is amongst the most frequent causes of liver cirrhosis and hepatocellular carcinoma 1. |
| PubMedID- 26196216 | Since 2010, reports of infection with hepatitis e virus (hev) have increased in england and wales. |
| PubMedID- 24693316 | Gb virus c infection in patients with hiv/hepatitis c virus coinfection: improvement of the liver function in chronic hepatitis c. |
| PubMedID- 23270376 | Thus, infection in patients with chronic hepatitis c relapsers or non-responders to previous therapy has been an important public health problem and the possibility of an alternative to retreatment has been the focus of clinical investigations. |
| PubMedID- 22836592 | Depressive symptoms, other substance use (crack/cocaine, marijuana, and tobacco), co-infection with hepatitis c virus (hcv), and heavy drinking prior to enrollment were associated with trajectories involving future heavy drinking. |
| PubMedID- 25820703 | Background: chronic infection with hepatitis c virus (hcv) genotype 2 or 3 can be treated with sofosbuvir without interferon. |
| PubMedID- 21340533 | infection with hepatitis viruses can lead to acute hepatitis with the risk of developing liver failure. |
| PubMedID- 24932245 | Serological tests revealed that there was no infection with hepatitis b virus, hepatitis c virus, hiv and tubercle bacillus. |
| PubMedID- 22909008 | Limited infection with occult hepatitis b virus in drug users in the usa. |
| PubMedID- 26357633 | Chronic infection with hepatitis c virus (hcv) carries a significant global health burden in both children and adults, with approximately 3% of the world's population infected. |
| PubMedID- 20111582 | Exclusion criteria included chronic medical conditions, clinically significant abnormal laboratory parameters, infection with hepatitis b or c virus, or recent receipt of a vaccine or blood transfusion. |
| PubMedID- 22921476 | Baseline infection with hepatitis c or b was the only significant predictor of moving from low to elevated transaminase levels; 9 bup and 15 met participants showed extreme liver test elevations and were more likely than those without extreme elevations to have seroconverted to both hepatitis b and c during the study, or to use illicit drugs during the first 8 weeks of treatment. |
| PubMedID- 22946668 | Re-infection was associated with negative serum hepatitis b immunoglobulin (hbig), as measured by a microparticle capture enzyme immunoassay. |
| PubMedID- 22956751 | infection with hepatitis delta virus (hdv) always occurs in association with hepatitis b virus (hbv) and is a cause of significant morbidity and mortality. |
| PubMedID- 23923349 | The coexistence of occult hepatitis b with hepatitis c infection is of particular importance because of its added co-morbidity of liver enzymes elevation, increased severity of liver disease and increased risk of hepatocellular carcinoma. |
| PubMedID- 24821066 | The aim of this hospital-based study was to detect the prevalence of hev infection in patients with acute sporadic hepatitis in west bengal, india. |
| PubMedID- 23618464 | infection with hepatitis b virus (hbv) and hepatitis c virus (hcv) affects the liver and results in a broad spectrum of disease outcomes 1. |
| PubMedID- 22984515 | Overwhelming lines of epidemiological evidence have indicated that persistent infection with hepatitis c virus (hcv) is a major risk for the development of hepatocellular carcinoma (hcc). |
| PubMedID- 23516510 | Persistent infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) is the major cause of hepatocellular carcinoma (hcc) worldwide. |
| PubMedID- 24379784 | infection with other hepatitis viruses as hav, hbv, hdv, hcv, cmv, and ebv was excluded as well as consumption of drugs, alcohol and previous travels to endemic areas. |
| PubMedID- 26371878 | The relationship between age and infection with the hepatitis virus has previously been examined in several studies, with inconsistent results. |
| PubMedID- 23150799 | Moreover, these liver diseases can be worsened by co-infection with hepatitis d virus (hdv), a satellite virus that can propagate only in the presence of hbv (makino et al., 1987). |
| PubMedID- 20820946 | The vast majority of cases are a consequence of a preexisting chronic viral infection due to either hepatitis b with or without associated hepatitis d or hepatitis c . |
| PubMedID- 26576450 | A review of 64 cases of patients who experienced severe viral infections with hepatitis b, cytomegalovirus infection, and varicella-zoster virus after rituximab treatment demonstrated that the median time period from start of rituximab to diagnosis of viral infection was 5 months (range: 1–20 months); our cases fell within this range 6. |